LOW-DOSE OCTREOTIDE IS ABLE TO CAUSE A MAXIMAL INHIBITION OF THE GLYCEMIC RESPONSES TO A MIXED MEAL IN OBESE TYPE-2 DIABETIC-PATIENTS TREATED WITH INSULIN

被引:19
作者
GIUSTINA, A
GIRELLI, A
BUFFOLI, MG
CIMINO, A
LEGATI, F
VALENTINI, U
GIUSTINA, G
机构
[1] Cattedra di Clinica Medica, University of Brescia, Brescia
关键词
SOMATOSTATIN; OCTREOTIDE; TYPE-2; DIABETES; INSULIN TREATMENT; OBESITY;
D O I
10.1016/0168-8227(91)90052-F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Short-term studies have shown that octreotide, a long-acting somatostatin analog, blunts postprandial glycemic responses and reduces insulin requirement in insulin treated diabetic patients. The aim of our study was to investigate the effects of three single, different doses of octreotide on the glycemic response to a mixed meal in eight insulin treated type 2 diabetic patients after secondary failure with hypoglycemic agents. Previous treatments were substituted by regular insulin, 0.5 U/kg/day divided into three sc injections, for at least seven days. All patients received: (a) regular insulin (0.1 U/kg, sc) at 7.30 am; (b) octreotide 25-mu-g sc or (c) 50-mu-g sc or (d) 100-mu-g sc simultaneously with insulin but injected at different sites. From 8.00 to 8.15 the patients consumed a preconstituted fluid mixed meal of 250 ml. Following insulin alone a significant increase in blood glucose levels was observed after the meal. Abolished and not significantly different blood glucose responses to the meal after each of the three doses of octreotide were observed. Our findings suggest that with a low dose of octreotide (25-mu-g) it is possible to abolish the postprandial glycemic peak in type 2 diabetic patients treated with insulin.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 34 条
  • [11] CLINICAL EVALUATION OF SOMATOSTATIN AS A POTENTIAL ADJUNCT TO INSULIN IN MANAGEMENT OF DIABETES-MELLITUS
    GERICH, JE
    SCHULTZ, TA
    LEWIS, SB
    KARAM, JH
    [J]. DIABETOLOGIA, 1977, 13 (05) : 537 - 544
  • [12] EFFECTS OF SOMATOSTATIN ON PLASMA GLUCOSE AND GLUCAGON LEVELS IN HUMAN DIABETES-MELLITUS - PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
    GERICH, JE
    LORENZI, M
    SCHNEIDER, V
    KARAM, JH
    RIVIER, J
    GUILLEMIN, R
    FORSHAM, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (11) : 544 - 547
  • [13] THE EFFECTS OF SMS 201-995 (SANDOSTATIN) ON METABOLIC PROFILES IN INSULIN-DEPENDENT DIABETES-MELLITUS
    GROSSMAN, LD
    SHUMAK, SL
    GEORGE, SR
    SINGER, W
    ZINMAN, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (01) : 63 - 67
  • [14] THE EFFECTS OF THE SOMATOSTATIN ANALOG SMS 201-995 ON CARBOHYDRATE HOMEOSTASIS OF INSULIN-DEPENDENT DIABETICS AS ASSESSED BY THE ARTIFICIAL ENDOCRINE PANCREAS
    HADJIDAKIS, DJ
    HALVATSIOTIS, PG
    IOANNOU, YJ
    MAVROKEFALOS, PJ
    RAPTIS, SA
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1988, 5 (02) : 91 - 98
  • [15] EFFECTS OF SOMATOSTATIN ON GASTROINTESTINAL PROPAGATION AND ABSORPTION OF ORAL GLUCOSE IN MAN
    JOHANSSON, C
    WISEN, O
    EFENDIC, S
    UVNASWALLENSTEN, K
    [J]. DIGESTION, 1981, 22 (03) : 126 - 137
  • [16] EFFECTS OF SMS 201-995 ON INTERMEDIARY METABOLISM AND ENDOCRINE STATUS IN NORMAL AND DIABETIC HUMANS
    JOHNSTON, DG
    DAVIES, RR
    ALBERTI, KGMM
    MILLER, M
    TURNER, SJ
    WATSON, M
    ORSKOV, H
    [J]. AMERICAN JOURNAL OF MEDICINE, 1986, 81 (6B) : 88 - 93
  • [17] KAHN S, 1988, CLIN DIABETES MELLIT, P268
  • [18] EFFECT OF THE LONG-ACTING SOMATOSTATIN ANALOG SMS-201-995 ON THE GLYCEMIC CONTROL IN INSULIN-TREATED DIABETICS
    KARAMANOS, B
    TOLIS, G
    ZOUPAS, C
    KARDOYIANNIS, T
    BENROUBI, M
    ALIVISATOS, J
    YOTIS, A
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 : 262 - 266
  • [19] PROLONGED SUPPRESSION OF INSULIN RELEASE BY A SOMATOSTATIN ANALOG
    LIEN, EL
    GARSKY, VM
    [J]. ENDOCRINOLOGY, 1978, 103 (01) : 81 - 85
  • [20] SEVERE HYPOGLYCEMIA AS A SHORT-TERM SIDE-EFFECT OF THE SOMATOSTATIN ANALOG SMS 201-995 IN INSULIN-DEPENDENT DIABETES-MELLITUS
    NAVASCUES, I
    GIL, J
    PASCAU, C
    SENEN, D
    SERRANORIOS, M
    [J]. HORMONE AND METABOLIC RESEARCH, 1988, 20 (12) : 749 - 750